Article
Implementation of OCM does not have to be a burden. Dr. Gor explains the implementation of OCM, potential cost savings and utilization with non-oncology patients.
Precision Oncology in NSCLC: Overcoming Patient Selection Barriers
Five Years Later: Ongoing COVID-19 Challenges, Next Steps
Dr Yehuda Handelsman on How DCRM 2.0 Guidelines Refine CRM Disease Management
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
Early Diabetes Screening in Pregnancy: Challenges and Opportunities
Addressing Ovarian Cancer Outcome Disparities With Cultural Understanding, Disaggregated Research